Blood Flow Mismatch in Pancreatic Cancers Winston Salem NC

Finnish researchers say they have identified a blood-flow metabolism mismatch that predicts pancreatic cancer aggressiveness. The investigators used a three-dimensional imaging technique called positron emission tomography (PET) to measure blood flow and glucose consumption -- a measure of general metabolic activity of a tissue -- in 26 people.

Dr.Eugene Paschold
(336) 277-8800
1010 Bethesda Ct
Winston Salem, NC
Gender
M
Education
Medical School: Bowman Gray Sch Of Med Of Wake Forest Univ
Year of Graduation: 1978
Speciality
Oncologist
General Information
Hospital: Wilkes Reg Med Ctr, N Wilkesboro, Nc
Accepting New Patients: Yes
RateMD Rating
3.5, out of 5 based on 4, reviews.

Data Provided by:
Eugene Paschold
(336) 277-8800
1010 Bethesda Ct
Winston Salem, NC
Specialty
Hematology / Oncology

Data Provided by:
Thomas H Grote
(336) 277-8800
1010 Bethesda Ct
Winston Salem, NC
Specialty
Hematology / Oncology, Medical Oncology

Data Provided by:
Kevin Patrick Mc Mullen, MD
Medical Center Blvd,
Winston Salem, NC
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Mayo Med Sch, Rochester Mn 55905
Graduation Year: 1994

Data Provided by:
Susan Anitra Melin
(336) 716-2255
Medical Center Blvd
Winston Salem, NC
Specialty
Hematology, Medical Oncology

Data Provided by:
Volker Wilhelm Stieber
(336) 718-5095
3333 Silas Creek Pkwy
Winston Salem, NC
Specialty
Radiation Oncology

Data Provided by:
Timothy S Collins
(336) 277-8800
1010 Bethesda Ct
Winston Salem, NC
Specialty
Family Practice, Internal Medicine, Hematology / Oncology, Emergency Medicine

Data Provided by:
DeNise A LeVitan
(336) 716-2255
Medical Center Blvd
Winston Salem, NC
Specialty
Medical Oncology

Data Provided by:
James Anthony Palermo, MD
(336) 527-7577
Medical Center Blvd,
Winston Salem, NC
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Univ Of Nc At Chapel Hill Sch Of Med, Chapel Hill Nc 27599
Graduation Year: 1997

Data Provided by:
Arthur Edward Frankel, MD
(336) 716-3313
Med Center Dr Hanes 4046
Winston-Salem, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Harvard Med Sch, Boston Ma 02115
Graduation Year: 1973

Data Provided by:
Data Provided by:

Blood Flow Mismatch in Pancreatic Cancers

Provided By:

WEDNESDAY, Aug. 26 (HealthDay News) -- Finnish researchers say they have identified a blood-flow metabolism mismatch that predicts pancreatic cancer aggressiveness.

The investigators used a three-dimensional imaging technique called positron emission tomography (PET) to measure blood flow and glucose consumption -- a measure of general metabolic activity of a tissue -- in 26 people. The researchers noted that blood flow in malignant tumors was 60 percent less than in normal pancreatic tissue.

The findings may help explain why many pancreatic cancer patients have a poor response to radiation treatment and chemotherapy, the study authors noted in their report published Aug. 25 in Clinical Cancer Research.

"Imaging of several of these tumor parameters might be important for the planning and success of [cancer] therapies," study author Dr. Gaber Komar, research fellow at the Turku PET Center, said in a news release from the American Association for Cancer Research. "We believe that a better understanding of these mechanisms may help overcome the general treatment resistance of pancreatic cancer."

"This study confirms that blood flow metabolism mismatch exists in pancreatic tumors, similar to other cancers such as breast and lung cancers, and predicts poor patient outcome," Dr. David Mankoff, a professor of radiology, medicine and bioengineering at the University of Washington in Seattle, said in the news release.

"A blood flow metabolism mismatch by PET appears to be associated with cancer aggressiveness and treatment resistance. We've only recently recognized this pattern as a result of advantages in functional imaging methods," added Mankoff.

More information

The American Cancer Society has more about pancreatic cancer.

SOURCE: American Association for Cancer Research, news release, Aug. 25, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com